DPT Enhances Capabilities at its San Antonio Center of Excellence
News Oct 31, 2014
DPT Laboratories has announced the implementation of a high-speed bottle filling center at its San Antonio location.
One of three DPT Centers of Excellence, the San Antonio location is purpose-built for semi-solids and liquids to support comprehensive pharmaceutical manufacturing needs. The new high-speed bottle filling center provides large-scale production capacity, and maximizes efficiency.
“We’re committed to investing in new capabilities and expanding services for our customers,” said Lyle Flom, Vice President and General Manager, San Antonio Site Operations.
“The addition of this high-speed filling center supports current demand, provides for future growth and helps DPT maintain its leadership position in semi-solid and liquid manufacturing.”
The new line significantly increases the rate of production for finished goods bottle manufacturing - up to 200 units per minute - and creates opportunities for growth in its large scale bulk manufacturing areas. With increased throughput capability, DPT now has the opportunity to provide bright stock supply chain services to clients seeking an external solution to their private label manufacturing needs.
“Our regulatory and customer service track record speaks to our ability to effectively deliver our customer’s production needs today. This high-speed filling center will enhance that ability for years to come,” said Flom.
As DPT’s Center of Excellence for Semi-solids and Liquids, the San Antonio location provides cGMP pilot, clinical and commercial scale manufacturing for prescription and over-the-counter products.
It includes a 60,000-square-foot cGMP aerosol manufacturing facility, a 225,000-square-foot raw material dispensing and distribution center and a 150,000-square-foot compounding, fill and finish area.
Worms Exhibit Fear and Respond to Anti-anxiety MedsNews
A team of investigators has uncovered new clues about the mechanisms of fear and anxiety through an unlikely creature: the tiny nematode worm.READ MORE
Domainex Appoints Dr Bodo Spori as Head of Business Development for EuropeNews
Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce the appointment of Dr Bodo Spori as Head of Business Development for Europe.READ MORE
Medherant Expands Team with Appointment of David Davies as Head of DevelopmentNews
Medherant Ltd, a leader in next-generation transdermal drug delivery, is pleased to announce the appointment of a new senior executive, David Davies, as Head of Development.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Pharmacy and Clinical Research
Jul 16 - Jul 17, 2018